PreveCeutical Medical Inc. is a health sciences company dedicated to developing innovative preventive and curative therapies by integrating natural compounds with advanced scientific research. Founded in 2015 and headquartered in Vancouver, the company focuses on unmet clinical needs, addressing diverse areas such as diabetes, obesity, pain management, neurological disorders, and cancer. It advances proprietary programs including nature-identical peptides and cannabinoid sol-gel delivery systems designed for targeted treatments like non-addictive analgesics. Its collaborative partnerships with leading academic institutions in Australia and Canada support research and commercialization efforts. PreveCeutical aims to improve health outcomes through novel therapies that harness nature and science, playing a significant role in the preventive healthcare sector.
Markedsdata leveret af TwelveData og Morningstar